TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the NetherlandsKaruna R. M. van der Meij, Marjan M. Weiss, Angelique J. A. Kooper et al.|The American Journal of Human Genetics|2019Cited by 378
Prenatal SNP array testing in 1000 fetuses with ultrasound anomalies: causative, unexpected and susceptibility CNVsMalgorzata I. Srebniak, Diane Van Opstal, Karin E. M. Diderich et al.|European Journal of Human Genetics|2015Cited by 80
Genomic SNP array as a gold standard for prenatal diagnosis of foetal ultrasound abnormalitiesMalgorzata I. Srebniak, Robert‐Jan H. Galjaard, Marjan Boter et al.|Molecular Cytogenetics|2012Cited by 75
Benefits and Burdens of Using a SNP Array in Pregnancies at Increased Risk for the Common AneuploidiesDiane Van Opstal, Malgorzata I. Srebniak, Femke de Vries et al.|Human Mutation|2014Cited by 51
Noninvasive prenatal testing as compared to chorionic villus sampling is more sensitive for the detection of confined placental mosaicism involving the cytotrophoblastDiane Van Opstal, Malgorzata I. Srebniak, Geerke M. Eggenhuizen et al.|Prenatal Diagnosis|2020Cited by 36